AxoGen (NASDAQ: AXGN) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $14.38 million.

For earnings history and earnings-related data on AxoGen (AXGN) click here.